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Abstract 
Background 
Prescribing that is not concordant with guidelines is increasingly referred to as clinical inertia 
(CI). However, CI may be only apparent, and the absence of decision may actually reflect 
appropriate inaction as a result of good clinical reasoning. Our study aimed to: (i) elucidate 
GPs’ beliefs regarding CI and the risk of CI in their own practice, (ii) identify modifiable 
provider-related factors associated with CI. 
Methods 
We conducted 8 group interviews with 114 general practitioners (GP) in Belgium, and used 
an integrated approach of thematic analysis. 
Results 
Our results call for a redefinition of CI, in order to take into account the GPs’ extended 
health-promoting role, and acknowledge that inaction or delayed action follows a process of 
clinical reasoning that takes into account the patients’ preferences, and that is appropriate 
most of the time. However, the participants in our study did acknowledge that the risk of CI 
exists in practice. The main factor of such a risk is when GPs feel overwhelmed and 
disempowered, due to characteristics of either the patients or the health care system, 
including contradictions between guidelines and reimbursement policies. 
Conclusions 
Although situations of clinical inertia exist in practice and need to be prevented or corrected, 
the term clinical inertia could potentially increase the already existing gap between general 
practice and specialised care, whereas sustained efforts toward more collaborative work and 
integrated care are called for. 
Background 
Failure to treat to target, or prescribing that is not concordant with guidelines are increasingly 
being referred to as clinical inertia (CI). Phillips et al. [1] first coined the term, which they 
defined as a failure to initiate or intensify therapy when indicated, or a failure to act despite 
recognition of the problem [1]. Alongside patient non-adherence to treatments, CI is believed 
to be a major factor that contributes to inadequate management of chronic conditions [2,3]. It 
has been suggested that CI related to management of diabetes, hypertension and lipid 
disorders may contribute up to 80% of heart attacks and strokes [4]. As it associates with 
poor control of risk factors known to cause long-term health problems, CI has an economic 
impact alongside medical consequences [5-7]. 
O’Connor et al. [2] postulated three classes of factors leading to CI: factors related to (i) 
providers, (ii) patients, and (iii) the system, with an estimated relative contribution of 50%, 
30% and 20% respectively [2]. Other authors report up to 75% provider-related factors [8]. 
The three provider-related factors that were initially defined by Phillips et al. [1] are assumed 
to be the most common contributors to CI [2,4,9]: (i) providers’ overestimation of the care 
they give; (ii) providers’ use of ‘soft’ reasons to avoid therapy; (iii) providers’ lack of 
education, training or organisation for achieving therapeutic goals. 
This list of factors is of little help in overcoming CI in practice. Indeed, practitioners need to 
be helped to overcome CI rather than systematically blamed for inaction [10], the latter being 
otherwise occasionally appropriate. Indeed, as summarised by Reach [11], clinical inaction 
may be called “true” CI only if: (i) a recommendation exists; (ii) the provider knows the 
recommendation; (iii) the provider believes the recommendation applies to the patient; (iv) 
the provider has the necessary resources to apply the recommendation; (v) the provider does 
not apply the recommendation for a particular patient, even though the conditions 1 to 4 are 
present [11]. Following this definition, non-adherence to guidelines may correspond to 
appropriate inaction as a result of good clinical reasoning. As shown in our recent literature 
review [12], actual CI is therefore difficult to observe and distinguish from appropriate 
inaction. It should not be evidenced without a careful investigation of a practitioner’s 
reasoning underlying their decisions. Moreover, in order to help anticipate the risk of CI in 
practice, it is necessary to understand which modifiable and non-modifiable factors underlie 
CI. Our study aimed to elucidate GPs’ beliefs regarding the risk of CI in their own practice, 
and personal modifiable factors associated with the risk of CI. 
Methods 
We conducted an exploratory qualitative study through group interviews among a sample of 
general practitioners (GP) in the Wallonie-Bruxelles Region (the French speaking part of 
Belgium). All participants were members of the same scientific society (Société Scientifique 
de Médecine Générale - SSMG). Over 40% of all GPs in the French speaking part of 
Belgium are members of SSMG, thus ensuring truthworthiness of our study. As part of their 
vocational training, members of SSMG from a same geographical area meet regularly around 
topics of interest to their practice. We used the opportunity of these existing practice-sharing 
encounters to conduct our interviews. In accordance with the local group coordinators, the 
GPs were informed beforehand of the topic of the discussion through a letter co-signed by the 
first author (IA) and the medical coordinator of SSMG. The practitioners who accepted to 
participate in our study were asked to inform the coordinator of their group that they would 
participate. We opted for interviews during such formal natural groups [13], rather than 
purposively sampled groups, as we hypothesized that the GPs would feel more comfortable 
discussing the issues surrounding CI in the familiar setting of their regular meetings. Our 
sample involved a total of 114 GPs in 8 group interviews, between October and December 
2012. After the 5 first focus groups, a meeting of the steering committee (co-authors) was 
organised in order to refine the emerging themes and discuss implications for practice. After 
3 more focus groups, as no new themes emerged, descriptive saturation of data was reached. 
The participants’ characteristics are shown in Table 1. Although sampling representativeness 
may be a less important issue in qualitative research, it is worth stressing that the male/female 
ratio among the participants in our sample (58.9/41.2) was the same than the male/female 
ratio among the members of SSMG (59/41). 
  
 Table 1 Participants’ characteristics (n = 114) 
 n(%) Median (range) 
Gender   
Male 67(58,8)  
Female 47(41,2)  
Type of practice   
Single-handed practice 73(64)  
Group practice 34(29,5)  
Mixed (people working in more than one practice) 7(6,5)  
Setting   
Urban 66(58)  
Rural 48(42)  
Work experience   
Median duration of work experience  31,3(2–40) 
GPs with less than 10 years of practice 11(9,6)  
GPs with over 35 years of practice 17(15,5)  
Data collection 
A standardised procedure was adopted for the data collection in every group. Two researchers 
were present at every meeting, and moderated the focus group discussions: The first author 
would introduce the topic with a brief review of the literature on IC. The group discussion 
would then be moderated by the second author. The research interviews were guided by two 
categories of open-ended questions consistent with the objectives of the study: (i) GPs’ 
beliefs regarding the risk of CI in their own practice, (ii) factors associated with CI. The 
duration of the discussions was limited to two hours. At the end of every focus group, there 
was a debriefing between the two researchers to discuss the most important themes that had 
emerged, and possible similarities and differences to other focus groups. 
Data analysis 
All focus groups were audio-taped and transcribed verbatim for analysis. As part of a process 
of respondent validation and error reduction, every participant received a synthesis of their 
group’s discussion, and was invited to share comments or further information directly with 
the researchers, either over the phone or by e-mail. We received feedback from six (6) 
participants, representing 5 different groups. Three (3) participants thanked the researchers 
for the discussion and the follow-up, and formally validated the synthesis. Two participants 
explained how the ideas shared during the focus group were further discussed within their 
groups, one stressing that it had made him personally more aware of the risk of CI in his own 
practice. The last participant informed the researchers of a TV programme relevant to the 
topic of CI. The participants’ comments did not add much to our analysis in terms of thematic 
contents, but confirmed the relevance of addressing the sensitive issue of CI with GPs. 
The transcripts were analysed using an integrated approach of categorisation: A start list of 
two codes reflecting the research objectives was used as a framework to organise the thematic 
categories that were inductively created through careful revision of the transcribed material 
[14,15]. To ensure validity of the findings and interpretations, the first and second authors 
independently coded the transcripts and met at regular intervals to discuss emerging 
categories. As already stated, the members of the steering committee (co-authors) were 
invited to reflect and comment on the analysis process after 5 focus groups. The study was 
stopped after 8 groups, as no new themes were emerging, meaning that descriptive saturation 
was achieved. Our results hereafter are illustrated with individual quotations from the various 
focus-groups [16]. 
Ethics 
Our study did not involve any patients nor patients’ relatives, nor did it require that patient 
data be shared with the researchers. Our study does therefore not fall within the scope of the 
Belgian Law of 7 May 2004 on Human experiments, and did therefore not require the 
approval of an ethics committee, nor that informed consent forms be signed by the 
participants. 
Ethical considerations were present however at all stages of the project: Every GP was 
personally informed of the study and invited to knowingly join (or not) the focus group 
interview several weeks before the encounter ; the interview process was conducted with a 
non-judgmental attitude and was very respectful of the GPs’ perceptions and self-reported 
experiences regarding the phenomenon of CI in their own practice; last but not least, every 
GP within a group was sent a synthesis of the discussion within that group, and was thus 
given the possibility to comment personally, either by e-mail or over the phone, on the 
synthesis of their interview. 
Results 
GPs’ beliefs regarding CI and the risk of CI in their own practice 
To initiate a discussion about CI in general practice raised mixed feelings. It initially made 
most participants uneasy. In addition to questioning the applicability of guidelines in some 
situations, the concept of “double-bind” was raised to explain GPs’ difficulty in complying 
with guidelines in some occasions. Moreover, the GPs’ called for a redefinition of CI, in 
order to take into account their health-promoting role and to acknowledge that most decisions 
are taken as a result of a complex process of clinical reasoning, and should not be mistaken 
for CI. 
Mixed feelings and perceptions of a double-bind 
The GPs generally expressed mixed feelings about the concept of CI, which was new to 
them. On the one hand they saw the discussion on CI as very interesting, stimulating, and 
revealing: “it encourages us to look at our own practice through a critic’s eye (FG6). Or: 
“Now that I am aware of the risk of CI, will I look differently at my files? Will I change my 
practice or examine more critically why I don’t change it? I am curious to see what 
happens…” (FG4). On the other hand, the topic raised feelings of unease and guilt: “It’s 
about what we should do, but currently do not do (…) it’s about feeling guilty for not doing 
well in some occasions” (FG1). Quite often the term was even perceived as insulting: “It’s a 
very negative term. It conveys that we are passive, that we don’t do anything… (FG4).” 
According to the GPs, the message that is implicitly conveyed with CI is that GPs need to 
prescribe more. This injunction was perceived as being in total contradiction with the need to 
comply at the same time with the healthcare system’s demand to reduce costs. The concept of 
“double-bind” was raised to describe the complexity of the GPs’ role and their feelings of 
powerlessness in some situations: “If we strictly prescribed everything as recommended in 
the guidelines…wouldn’t we be blamed for over-prescribing compared to our colleagues, 
thus impacting negatively on the budget of the healthcare system?” (FG4). 
To care for patients and promote their health, rather than to treat to target 
The narrow definition around prescribing to target, was perceived by the GPs as too 
restrictive in the context of general practice: “A patient cannot be reduced to figures! Figures 
alone cannot reflect the complexity of clinical cases. Every situation is unique! We do have 
targets for our patients, but targets need to be adapted to every patient’s individual 
situation” (FG2). The participants believed that a relevant definition of CI needs to include 
the GPs’ health-promoting role, in addition to that of treating patients. For instance, GPs 
acknowledged the presence of CI in situations where they might fail to provide timely 
preventative messages or adequate psychosocial support. They insisted that their role is to 
care for patients, which is a much broader objective than that of treating to target: “When my 
patient is a 75 year-old women with a blood pressure as high as 150(mmHg), I leave her 
alone! If she is happy to eat a little piece of cake every day, if she is happy with her life, and 
her glycaemia is 130 (mg/dL)…well, I won’t bother putting her on medication in order to 
lower her blood sugar level to 100, and her blood pressure to 13” (FG7). Guidelines were 
generally acknowledged as providing state of the art knowledge and were considered very 
important in indicating a direction rather than presenting a goal to achieve. However, the GPs 
expressed concern because of a great number of changing and sometimes contradictory 
guidelines, making it difficult to know what to do in some situations. They also pointed out 
the fact that highly specialised guidelines may not offer sufficient guidance in cases of co-
morbidity. Moreover, the validity of guidelines was questioned by some who thought that 
new guidelines might be issued in relation with the marketing of new pharmaceutical 
products. 
Appropriate inaction versus “true” CI 
There was a strong consensus both within the various groups and across the groups that the 
“failure to initiate or intensify a treatment according to guideline” is a common occurrence in 
general practice. However, the participants agreed that most decisions are taken after careful 
examination of the patients’ lives, personal objectives, possibilities and preferences, etc. 
Moreover, the decision not to prescribe more is justified in situations where the patient is 
already on a number of different drugs and GPs are aware that the prescription of a new drug 
might increase the risk of non-adherence or of losing track of a patient. Such decisions should 
be seen as the result of an appropriate decision following a complex process of clinical 
reasoning, rather than a manifestation of CI: “It’s like playing chess: you need to move your 
pawns step by step to achieve the best results possible instead of charging straight for the 
king… one move at a time. You mustn’t try to win the game in one go (…) Of course we have 
targets for our patients, but we adjust them for each individual patient.”(FG2). 
The participants in our study did however acknowledge that the risk of CI exists in practice: 
“Some patients do not understand what we mean if we don’t take at least 15 minutes to 
explain and explain again…We happen to be fed up, and not bother to explain twice.…there 
we may be blamed for CI.” (FG7) 
Personal risk factors of CI 
Across a variety of situations, a sense of being overwhelmed and feelings of disempowerment 
were the main common factors associated with the risk of CI. 
Feeling overwhelmed 
The lack of timely investigation to recognise and treat a problem emerged as the most 
common manifestation of CI, and was reported to be mainly due to factors of human error, 
such as tiredness, conflicting priorities (private and professional), lack of time, etc. “At the 
end of the day, after you saw 20, 30, 35 patients…you had a hard day. If you then see a 
patient with borderline values, a blood pressure that is not optimal, well, you tend to 
minimise a bit, you tend to convince yourself that it’s not the right time,that you’ll look at it 
next time. It’s not an excuse, but nobody is perfect. We also have our children to pick up at 
school or other conflicting priorities…” (FG5). 
Another reason for not investigating further during a consultation was linked to the attitude of 
some patients who address multiple demands to the doctor, either for themselves or for other 
family members: “Tonight, one of my last patients came because she had flu. She came with 
her son and husband. At the end of the visit she asked: “Did you receive my son’s and my 
husband’s blood tests?” By the way, the tests had been done two months ago. The son was 
OK, but the husband had type 2 diabetes, and his results were not brilliant. I still had one 
other patient to see before I could go home, prepare supper for my son, and get ready to be 
on time for our meeting tonight. I told the patient to come back.”(FG8) 
Regarding CI in relation to prescribing medication, an issue frequently reported was that of 
the amount of administrative work requested for some particular prescriptions: “You are 
aware that you should be doing something, but you don’t. Why is that? Because you are tired, 
because you need to find the right form…I tell you what -as far as I am concerned, my CI is 
mainly related to paperwork. If I want to prescribe paracetamol, and I need to find the form, 
which of course is at the bottom of the pile, for the patient to pay 1,50 instead of 3,50…well, 
sometimes I feel it’s not worth the effort.” (FG7) 
Feeling disempowered 
A sense of powerlessness was reported to be involved in CI. Patients who are particularly 
difficult to treat because they are non-adherent, for instance, or aggressive, or denying their 
medical needs, etc. may induce a sense of powerlessness on the part of the physicians. “We 
are there to explain, we take some time with them to explain what their problem is, what diet 
they should adhere to, what they are exposed to if they don’t change their habits…yet, they do 
what they want…We do try to increase their motivation regularly. But after some time, some 
of them make us discouraged and hopeless.” (FG3). 
Moreover, GPs complained about constraints imposed by the healthcare system that 
sometimes limit their autonomy, and make it difficult to prescribe according to guidelines. A 
particularly difficult situation for GPs to handle is when they find out that the medication that 
is recommended according to best practice guidelines is not reimbursed in their country (in 
Belgium by RIZIV/INAMI, the National Institute for Health and Disability Insurance), or 
when reimbursement is contingent either on prior authorization from RIZIV/INAMI, or the 
need that patients visit specialists instead of GPs (as is the case for patients with type 1 
diabetes in Belgium). 
Discussion 
The results of our group interviews show that non-adherence to guidelines in general practice 
should not be systematically labeled CI. The Belgian health-care system is characterized by 
fee-for-service, free access to all levels of care, mostly small single-handed practices in 
primary care, no compulsory guidelines (which are available but are not strictly “followed”), 
no real quality assurance, and a tradition of hospital-centered disease-oriented care, all of 
which can make GPs frustrated about working conditions. Despite this, the GPs in our study 
displayed great commitment to their work, and believed that prevalent definitions of CI did 
not take sufficiently into account the active role of the patient in the consultation and medical 
decision-making process, nor the breadth and complexity of their role, which includes 
tackling sociocultural determinants of health as much as medical and pharmacological ones. 
When situations of CI were actually acknowledged, these were more often connected with a 
lack of investigation to timely diagnose and treat a problem than with failing to prescribe 
more. Insufficient delivery of health-promotion and patient-education messages were 
considered a form of CI as well. Across a variety of cases of CI in which patient and system 
factors were involved, feelings of being overwhelmed and disempowered was a common 
issue that emerged as an important factor of CI. Again, appropriate decisions not to adhere to 
guidelines in specific situations, for specific patients, at specific times are not to be mistaken 
for CI. As far as prescriptions are concerned, the participants in our study saw their decisions 
as appropriate most of the time although they were not always concordant with guidelines. 
Hence, the definition by Philips et al. [1], which emphasizes prescription failures, was 
considered too narrow, and irrelevant to general practice. 
At the heart of evidence-based medicine is the providers’ capacity to integrate individual 
clinical expertise with the best available clinical evidence from systematic research [17]. 
Although the concept of CI arises in the context of evidence-based practices, attempts to 
define it tend to overlook the importance of adjusting care in individual cases. Indeed the 
main ways of measuring CI, which are based on target, timeframe, and decision to intensify 
therapy (or not) [2,4] are not sufficient to determine whether individual decisions to increase 
or not increase therapy might be appropriate for a specific patient [18,19]. As reflected by the 
participants in our study, in order to adequately assess CI, it is necessary to define 
intermediate outcomes that incorporate information on, and justification of treatment 
decisions that are made [20]. In the absence of such information, CI may be only apparent, 
and actually reflect good clinical practice [18]. 
Application of clinical guidelines in the real world is somewhat problematic because there are 
practitioner, patient and system variables at play. However, clinicians only have direct 
control over the first. Finally, the use of the word ‘inertia’ to define a concept in Medicine 
(which would be better described as inaction) may initially have resulted from the mistaken 
belief that ‘inertia’ in Physics actually implies some obstacle or reluctance in changing 
motion. Describing the choice to maintain treatment without any change as ‘inert’ can give 
the incorrect impression of lethargy, and is rather debatable semantically. 
The main strengths of our study lie in the number of group interviews and the total number of 
participants across the country, aiming for saturation of the data and internal validity. 
Independent coding by two researchers and discussions at several stages with a scientific 
committee including representatives of several medical specialities and two GPs, are another 
strength of our study. Regarding the researchers’ characteristics that might have influenced 
the study, whereas one researcher (first author) is very experienced in conducting qualitative 
research in the field of health care and clinical communication, the other researcher (second 
author) is a research nurse with extensive clinical experience and thorough knowledge of 
evidence-based practice. A strength of the study therefore lies in their complementarity to 
conduct the study. Moreover, none of them is a medical doctor. Although it might be argued 
that professions other than physicians are not given enough credence by physicians in other 
circumstances, we believe that this was a strength for our study, as we approached the 
physicians without a priori representations of how they should be dealing with the risk of CI 
in their practice. The main limitation lies with our choice of group interviews. Although it 
enabled us to collect useful information on physicians’ opinions regarding the much debated 
concept of CI, in-depth individual interviews might have yielded richer data regarding 
personal experience of CI. 
Conclusions 
Our results suggest that non-adherence to clinical guidelines should not be labelled CI in the 
absence of careful investigation of the patient’s role and the physician’s motives regarding 
decisions not to act or to postpone therapeutic action in some situations. We believe that the 
term CI could potentially increase the already existing gap between general practice and 
specialised care, whereas sustained efforts toward more collaborative work and integrated 
care are called for. 
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